GLIPR1 and prostate carcinoma: The same study also found that GLIPR1 overexpression in prostate cancer cell lines led to a reduction in MYC expression due to GLIPR1 directly decreasing MYC transcription as well as promoting the ubiquitination and degradation of MYC protein [32].